Low‐grade inflammation, endothelial activation and carotid intima‐media thickness in type 2 diabetes
Open Access
- 15 July 2004
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 256 (2) , 119-127
- https://doi.org/10.1111/j.1365-2796.2004.01350.x
Abstract
Objectives. The objective of this study was to assess the relationship between inflammation, endothelial activation and incipient atherosclerosis in type 2 diabetes. Design. Cross‐sectional study. Setting and subjects. We studied 239 type 2 diabetic patients [71 with clinical cardiovascular disease (CVD)] and 78 healthy control subjects, aged 50–75 in a single research centre. Methods. Carotid intima‐media thickness (IMT) was determined by ultrasound. Circulating intracellular adhesion molecule‐1, vascular cell adhesion molecule‐1, E‐selectin, ultra‐sensitive C‐reactive protein, human serum amyloid A, interleukin‐6, monocyte colony‐stimulating factor, secretory nonpancreatic phospholipase A2 type IIA, glucose, HbA1c, and lipid/lipoprotein variables were measured. Results. Carotid IMT was significantly thicker in diabetic patients than healthy controls across the whole age range. IMT was also thicker in diabetic patients with, than without, CVD, but this difference disappeared after controlling for confounding factors. Concentrations of the inflammatory and endothelial markers except IL‐6 were significantly higher in the diabetic patients than in healthy controls, but comparable in diabetic patients with and without CVD. The main determinants of IMT in the diabetic patients were blood pressure, age and diabetes duration. Conclusions. Low‐grade inflammation and endothelial activation are increased in diabetic patients but do not associate with IMT or clinical CVD. The inflammatory reaction seems to be rather a feature of the metabolic syndrome than a direct determinant of atherosclerosis.Keywords
This publication has 39 references indexed in Scilit:
- Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and PreventionCirculation, 2003
- Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crimeNature Medicine, 2002
- Effects of Inflammation on High-Density LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Inflammation and AtherosclerosisCirculation, 2002
- Phospholipase A2in Vascular DiseaseCirculation Research, 2001
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Is Type II diabetes mellitus a disease of the innate immune system?Diabetologia, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose toleranceAtherosclerosis, 1998
- Cellular Consequences of the Association of ApoB Lipoproteins With ProteoglycansArteriosclerosis, Thrombosis, and Vascular Biology, 1997